A loss of circ-MYBL2 in mutant cells resulted in a decline in FLT3 phosphorylated kinases and impairment of STAT5 phosphorylation, a key downstream protein of oncogenic FLT3 and crucial for aberrant leukemia cell growth. Here, MYBL2 is linked to leukemia.